Medicines Consent Notices




10 MARCH 2011 NEW ZEALAND GAZETTE, No. 26 769

Schedule

Product:
Codral Relief Mucus Cough & Cold

Active Ingredients:
Guaifenesin 20mg/mL
Phenylephrine hydrochloride 1mg/mL

Dosage Form:
Oral solution

New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited

Manufacturer:
Probiotec Pharma Pty Limited, Laverton North, Australia

Product:
Desitin® Rapid Relief

Active Ingredient:
Zinc oxide 40%w/w

Dosage Form:
Topical ointment

New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited

Manufacturer:
McNeill PPC Inc., Pennsylvania, United States of America

Product:
Neutrogena Blackhead Eliminating Daily Scrub

Active Ingredient:
Salicylic acid 2%w/w

Dosage Form:
Skin wash

New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited

Manufacturer:
Neutrogena Corporation, Los Angeles, United States of America

Product:
Octalbin

Active Ingredient:
Albumin 50g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Octapharma New Zealand Limited

Manufacturer:
Octapharma Pharmazeutika Produktions GmbH, Vienna, Austria

Product:
Octalbin

Active Ingredient:
Albumin 200g/L

Dosage Form:
Solution for infusion

New Zealand Sponsor:
Octapharma New Zealand Limited

Manufacturer:
Octapharma Pharmazeutika Produktions GmbH, Vienna, Austria

Product:
Pharmacist’s Own Cold & Flu Relief PE

Active Ingredients:
Codeine phosphate hemihydrate 6mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg

Dosage Form:
Tablet

New Zealand Sponsor:
PSM Healthcare Limited trading as API Consumer Brands

Manufacturer:
PSM Healthcare Limited trading as API Consumer Brands, Auckland, New Zealand

Dated this 3rd day of March 2011.

MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1505

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product:
Blackmores Macu-Vision

Active Ingredients:
Ascorbic acid 250mg
Cupric oxide 1.25mg equivalent to 1mg copper
D-alpha-Tocopheryl acid succinate 165mg equivalent to 200IU vitamin E
Zinc oxide 49.8mg equivalent to 40mg zinc

Dosage Form:
Film coated tablet

New Zealand Sponsor:
Blackmores Limited

Manufacturer:
Catalent Australia Pty Limited, Braeside, Australia

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 3rd day of March 2011.

MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go1508



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2011, No 26





✨ LLM interpretation of page content

🏥 Consent to the Distribution of New Medicines under the Medicines Act 1981 (continued from previous page)

🏥 Health & Social Welfare
3 March 2011
Medicines, Distribution, Consent, Codral Relief Mucus Cough & Cold, Desitin® Rapid Relief, Neutrogena Blackhead Eliminating Daily Scrub, Octalbin, Pharmacist’s Own Cold & Flu Relief PE
  • MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health

🏥 Provisional Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
3 March 2011
Medicines, Provisional Consent, Blackmores Macu-Vision
  • MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health